Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-04-000319
Filing Date
2004-05-03
Accepted
2004-05-03 17:21:31
Documents
9
Period of Report
2004-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o12774e6vk.htm 6-K 493667
2 GRAPHIC o12774o1277401.gif GRAPHIC 3212
3 GRAPHIC o12774o1277402.gif GRAPHIC 13446
4 GRAPHIC o12774o1277403.gif GRAPHIC 209420
5 GRAPHIC o12774o1277404.gif GRAPHIC 1612
6 GRAPHIC o12774o1277405.gif GRAPHIC 2078
7 GRAPHIC o12774o1277406.gif GRAPHIC 1888
8 GRAPHIC o12774o1277407.gif GRAPHIC 1666
9 GRAPHIC o12774o1277408.gif GRAPHIC 221968
  Complete submission text file 0001130319-04-000319.txt   951370
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 04774506
SIC: 2834 Pharmaceutical Preparations